Dr. Tuncer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Prospect St
Milford, MA 01757Phone+1 508-488-3700
Education & Training
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
- University of Alabama Medical CenterFellowship, Blood Banking/Transfusion Medicine, 2003 - 2004
- UMass Chan Medical SchoolResidency, Internal Medicine, 2002 - 2003
- SUNY Upstate Medical UniversityResidency, Internal Medicine, 2000 - 2002
- Istanbul University FomClass of 1997
Certifications & Licensure
- MA State Medical License 2005 - 2025
- RI State Medical License 2009 - 2014
- IL State Medical License 2007 - 2011
- AL State Medical License 2003 - 2004
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 119 citationsReal world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United StatesAnthony R. Mato, Meghan C. Thompson, John N. Allan, Danielle M. Brander, John M. Pagel
Haematologica. 2018-09-01 - 58 citationsTumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.Lindsey E. Roeker, Christopher P. Fox, Toby A. Eyre, Danielle M. Brander, John N. Allan
Clinical Cancer Research. 2019-01-01 - 53 citationsOutcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.Anthony R. Mato, Lindsey E. Roeker, John N. Allan, John M. Pagel, Danielle M. Brander
American Journal of Hematology. 2018-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: